Insight into Discovery of Next Generation Reversible TMLR Inhibitors Targeting EGFR Activating and Drug Resistant T790M Mutants

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|17|7|617-636

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.7, 2017-08, pp. : 617-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting enzyme inhibitors in drug discovery

By Copeland Robert A   Harpel Mark R   Tummino Peter J  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 967-978

Informa Healthcare

Access to resources Recommend Favorite

Discovery of Next Generation Inhibitors of HIV Protease

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 16, 2005-12 ,pp. : 1589-1607

Bentham Science Publishers

Access to resources Recommend Favorite

Insight into the Medicinal Chemistry of EGFR and HER-2 Inhibitors

By  

Current Medicinal Chemistry, Vol. 21, Iss. 11, 2014-04 ,pp. : 1336-1350

Bentham Science Publishers

Access to resources Recommend Favorite

HIV Protease Inhibitors - The Next Generation

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 2, 2002-04 ,pp. : 141-162

Bentham Science Publishers

Access to resources Recommend Favorite

An insight on hyaluronic acid in drug targeting and drug delivery

By Yadav Awesh   Mishra P.   Agrawal Govind  

Journal of Drug Targeting, Vol. 16, Iss. 2, 2008-02 ,pp. : 91-107

Informa Healthcare

Access to resources Recommend Favorite